secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001193125-24-141816
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics receives additional delisting notice, requests transfer to Nasdaq Capital Market
--------------------------------------------------------------------------------

- Nasdaq issued Additional Staff Determination on May 14, 2024, for continued noncompliance with $5M MVPHS Rule.
- Company failed to regain compliance by May 13, 2024 deadline; first flagged Nov 15, 2023.
- Company also deemed a 'public shell'; appeal hearing held April 23, 2024, decision pending.
- On May 15, 2024, Company requested transfer from Nasdaq Global Select to Nasdaq Capital Market; no guarantee of approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/0001193125-24-141816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/d800582d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-141816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer